Biopharmaceutical
100 Most Popular
Most Popular Under $25

Geron

$1.70
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.04 (2.44%) Today
+$0.02 (1.19%) After Hours

Why Robinhood?

You can buy or sell Geron and other stocks, options, ETFs, and crypto commission-free!

About

Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. Read More The company was founded by Michael D. West on November 28, 1990 and is headquartered in Menlo Park, CA.

Employees
17
Headquarters
Menlo Park, California
Founded
1990
Market Cap
305.68M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
5.51M
High Today
$1.72
Low Today
$1.65
Open Price
$1.65
Volume
614.15K
52 Week High
$6.99
52 Week Low
$0.9547

Collections

Biopharmaceutical
100 Most Popular
Most Popular Under $25
Biotechnology
Cancer Prevention
Pharmaceutical
Health
Medical

News

Yahoo FinanceMar 25

Edited Transcript of GERN earnings conference call or presentation 7-Mar-19 9:30pm GMT

Q4 2018 Geron Corp Earnings Call MENLO PARK Mar 25, 2019 (Thomson StreetEvents) -- Edited Transcript of Geron Corp earnings conference call or presentation Thursday, March 7, 2019 at 9:30:00pm GMT TEXT version of Transcript Scroll to continue with content Ad ================================================================================ Corporate Participants ================================================================================ * John A. Scarlett Geron Corporation - CEO, President & Chai...

168
Yahoo FinanceMar 21

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MENLO PARK, Calif., March 21, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (GERN) today reported that it has granted non-statutory stock options to purchase an aggregate of 78,400 shares of Geron common stock as inducements to two newly-hired employees in connection with commencement of employment with the Company. The stock options were granted on March 20, 2019 at an exercise price of $1.77 per share, which is equal to the closing price of Geron common stock on the date of grant. Each stock option grante...

4,275
Yahoo FinanceMar 14

Do Options Traders Know Something About Geron (GERN) Stock We Don't?

Investors in Geron Corporation GERN need to pay close attention to the stock based on moves in the options market lately. That is because the Mar 15, 2019 $1.50 Put had some of the highest implied volatility of all equity options today. What is Implied Volatility? Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could...

9,246

Earnings

-$0.05
-$0.04
-$0.04
-$0.03
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected May 9, After Hours

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.